Leping Li
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- Connexins and lens biology
Papers in
-
- RNA modifications and cancer 14
- Circular RNAs in diseases 12
- Connexins and lens biology 8
- Surgery 40
- Co-authors
- Changqing Jing (30 shared papers)Thomas W. White (9 shared papers)Caterina Sellitto (9 shared papers)Xiaobo Guo (18 shared papers)Liang Shang (30 shared papers)Hao Wu (12 shared papers)Wei Chong (13 shared papers)Jinshen Wang (18 shared papers)
- Journals
- World Journal of Gastroenterology (6 papers)Investigative Ophthalmology & Visual Science (4 papers)Cell Death and Disease (4 papers)Journal of Translational Medicine (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Leping Li
127 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 848
- Molecular Biology 1.5k
- Obstetrics and Gynecology 149
- Oncology 494
- Gastroenterology 63
Countries citing papers authored by Leping Li
This map shows the geographic impact of Leping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leping Li more than expected).
Fields of papers citing papers by Leping Li
This network shows the impact of papers produced by Leping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leping Li. The network helps show where Leping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Leping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 169 | |
| 2 | 2020 | 134 | |
| 3 | 2021 | 86 | |
| 4 | 2022 | 71 | |
| 5 | 2004 | 69 | |
| 6 | 2022 | 69 | |
| 7 | 2011 | 63 | |
| 8 | 2015 | 55 | |
| 9 | 2017 | 52 | |
| 10 | 1993 | 50 | |
| 11 | Upregulation of CD147 promotes cell invasion, epithelial-to-mesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer. | 2014 | 49 |
| 12 | 2007 | 49 | |
| 13 | 2017 | 45 | |
| 14 | 2015 | 45 | |
| 15 | 2014 | 43 | |
| 16 | 2017 | 43 | |
| 17 | 2003 | 42 | |
| 18 | 2016 | 40 | |
| 19 | 2010 | 37 | |
| 20 | 2015 | 37 |
About Leping Li
Leping Li is a scholar working on Molecular Biology, Surgery, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 143 papers that have together received 2.4k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (25 papers), Cancer-related molecular mechanisms research (19 papers), MicroRNA in disease regulation (16 papers), Gastrointestinal Tumor Research and Treatment (15 papers), RNA modifications and cancer (14 papers), Circular RNAs in diseases (12 papers), Colorectal Cancer Surgical Treatments (10 papers) and Connexins and lens biology (8 papers). The work is most often cited by research in Cancer Research (848 citations), Molecular Biology (1.5k citations), Obstetrics and Gynecology (149 citations), Oncology (494 citations) and Gastroenterology (63 citations). Leping Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Changqing Jing, Thomas W. White, Caterina Sellitto, Xiaobo Guo, Liang Shang, Hao Wu, Wei Chong, Jinshen Wang, Fengying Du and Zhen Fang. Their work appears in journals such as World Journal of Gastroenterology, Investigative Ophthalmology & Visual Science, Cell Death and Disease, Journal of Translational Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.